Surgical Management of Endobronchial Inflammatory Myofibroblastic Tumors

被引:33
作者
Thistlethwaite, Patricia A. [1 ]
Renner, John
Duhamel, David
Makani, Samir
Lin, Grace Y.
Jamieson, Stuart W.
Harrell, James
机构
[1] Univ Calif San Diego, Div Cardiothorac Surg, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
PLASMA-CELL GRANULOMA; RADIATION-THERAPY; LUNG; PSEUDOTUMOR; RESECTION; LESIONS;
D O I
10.1016/j.athoracsur.2010.09.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Endobronchial myofibroblastic tumors are neoplasms composed of clonal populations of smooth muscle cells and a variable lymphocytic inflammatory component. They represent a challenge with respect to diagnosis, classification, and surgical resection due to their infrequent occurrence. Methods. We retrospectively reviewed our experience with patients who had myofibroblastic tumors in the major airways over a 15-year period, in order to understand the incidence, natural biology, treatment, and long-term outcome of individuals with this type of neoplasm in an endobronchial location. Results. Between 1995 and 2010, 11 patients (9 female, 2 male) underwent surgical resection of a myofibroblastic tumor arising within the tracheobronchial tree. The mean age was 39.6 years (range, 22.3 to 53.6 years). All patients were symptomatic, with cough and dyspnea as the most common presenting complaints. Rigid bronchoscopy with endobronchial biopsy was utilized to establish the diagnosis in 9 of 11 patients. Laser-mechanical debulking was performed to relieve airway obstruction prior to operation in 10 of 11 patients. Because of wide submucosal infiltration of the neoplasms, surgical resection for complete removal was required for all individuals. Tracheal resection was performed in 3 patients, carinal resection in 1 patient, mainstem bronchial resection in 2 patients, sleeve resection in 3 patients, bilobectomy in 1 patient, and right lower lobectomy in 1 patient. Resection with tumor-free margins was accomplished in all patients. Mean tumor size was 2.3 cm (range, 1.5 to 3.5 cm). There were no operative deaths, with all patients alive and disease-free at a mean of 6.1 +/- 3.7 years. Conclusions. Complete surgical resection of inflammatory myofibroblastic tumors presenting in a major airway is safe and leads to excellent survival for patients with this uncommon disease. (Ann Thorac Surg 2011; 91: 367-72) (C) 2011 by The Society of Thoracic Surgeons
引用
收藏
页码:367 / 372
页数:6
相关论文
共 30 条
[1]  
BAHADORI M, 1973, CANCER, V31, P191, DOI 10.1002/1097-0142(197301)31:1<191::AID-CNCR2820310127>3.0.CO
[2]  
2-D
[3]  
Biselli R, 1996, CANCER, V77, P778, DOI 10.1002/(SICI)1097-0142(19960215)77:4<778::AID-CNCR25>3.0.CO
[4]  
2-X
[5]  
Brunn H., 1939, Journal of Thoracic Surgery, V9, P119, DOI 10.1016/S0096-5588(20)32030-4
[6]   Inflammatory pseudotumour of the lung presenting as an airway obstructive syndrome [J].
Calderazzo, M ;
Gallelli, A ;
Barbieri, V ;
Roccia, F ;
Pelaia, G ;
Tranfa, CME ;
Cavaliere, S ;
Zorzi, F .
RESPIRATORY MEDICINE, 1997, 91 (06) :381-384
[7]   Inflammatory pseudotumors of the lung [J].
Cerfolio, RJ ;
Allen, MS ;
Nascimento, AG ;
Deschamps, C ;
Trastek, VF ;
Miller, DL ;
Pairolero, PC .
ANNALS OF THORACIC SURGERY, 1999, 67 (04) :933-936
[8]   Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases [J].
Cessna, MH ;
Zhou, H ;
Sanger, WG ;
Perkins, SL ;
Tripp, S ;
Pickering, D ;
Daines, C ;
Coffin, CM .
MODERN PATHOLOGY, 2002, 15 (09) :931-938
[9]   EXTRAPULMONARY INFLAMMATORY MYOFIBROBLASTIC TUMOR (INFLAMMATORY PSEUDOTUMOR) - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 84 CASES [J].
COFFIN, CM ;
WATTERSON, J ;
PRIEST, JR ;
DEHNER, LP .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (08) :859-872
[10]  
COLBY TV, 1995, TUMORS LOWER RESP TR, P327